Clorox seeking buyer for loss-making vitamins business, Reuters reports

Clorox (CLX) has has been working with investment bank Goldman Sachs (GS) as it seeks to sell its vitamins, minerals and supplements business after efforts to scale it led to major losses, four people familiar with the situation told Reuters’ Abigail Summerville. The VMS business represents just 3% of Clorox’s total net sales, but in 2021 it forced it to take a $267M writedown as its vitamins and supplements lost market share to better known brands, the report noted. Reference Link